5Narta U K, Kanwar S S, Azmi W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia[ J]. Crit Rev Oncol Hematol, 2007, 61 ( 3 ) : 208-221.
6Khushoo A, Pal Y, Mukherjee K J. Optimization of extracellular production of recombinant asparaginase in Escherichia coli in shake-flask and bioreactor[J]. Appl Microbiol Biotechnol,2005,68 (2) : 189-197.
7Kotzia G A, Labrou N E. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase[J]. J Biotechnol, 2005,119 (4) : 309 -323.
8Duval M, Suciu S, Ferster A, et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies : results of a randomized European Organisation for Research and Treatment of Cancer - Children's Leukemia Group phase 3 trial [J]. Blood,2002,99(8):2734-2739.
9Rizzari C, Citterio M, Zuechetti M, et al. A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia [J]. Haematologica,2006,91 ( 1 ) :24-31.
10Alvarez O A, Zimmerman G. Pegaspargase-induced pancreatitis [ J ]. Med Pedlar Onco, 2000,34 ( 3 ) :200-205.
